Ethical Transparency and Economic Medicalization
This article introduces the concept of economic medicalization where non-medical problems are transformed into medical problems in order to achieve the objective of corporate shareholder wealth maximization. Following an overview of the differences in ethical norms applicable to medical ethics and b...
| Authors: | ; |
|---|---|
| Format: | Electronic Article |
| Language: | English |
| Check availability: | HBZ Gateway |
| Journals Online & Print: | Drawer...
|
| Fernleihe: | Fernleihe für die Fachinformationsdienste |
| Published: |
Springer Science + Business Media B. V
2009
|
| In: |
Journal of business ethics
Year: 2009, Volume: 86, Issue: 3, Pages: 313-325 |
| Further subjects: | B
Medicalization
B Bioethics B Medical Ethics B shareholder wealth maximization |
| Online Access: |
Volltext (JSTOR) Volltext (lizenzpflichtig) |
MARC
| LEADER | 00000caa a22000002 4500 | ||
|---|---|---|---|
| 001 | 1785634232 | ||
| 003 | DE-627 | ||
| 005 | 20230331052952.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220112s2009 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s10551-008-9849-2 |2 doi | |
| 035 | |a (DE-627)1785634232 | ||
| 035 | |a (DE-599)KXP1785634232 | ||
| 035 | |a (DE-He213)s10551-008-9849-2-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 1 |2 ssgn | ||
| 100 | 1 | |a Poitras, Geoffrey |e VerfasserIn |4 aut | |
| 245 | 1 | 0 | |a Ethical Transparency and Economic Medicalization |
| 264 | 1 | |c 2009 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a This article introduces the concept of economic medicalization where non-medical problems are transformed into medical problems in order to achieve the objective of corporate shareholder wealth maximization. Following an overview of the differences in ethical norms applicable to medical ethics and business ethics, the economic medicalization of medical research practice and publication is examined in some detail. This motivates a general discussion of the problems involved in the ethical approval process for medical research that balances the interests of both business and government in the market for medical products and services. | ||
| 650 | 4 | |a Medical Ethics | |
| 650 | 4 | |a Bioethics | |
| 650 | 4 | |a Medicalization | |
| 650 | 4 | |a shareholder wealth maximization | |
| 700 | 1 | |a Meredith, Lindsay |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of business ethics |d Dordrecht [u.a.] : Springer Science + Business Media B.V, 1982 |g 86(2009), 3, Seite 313-325 |h Online-Ressource |w (DE-627)270937129 |w (DE-600)1478688-6 |w (DE-576)121465284 |x 1573-0697 |7 nnns |
| 773 | 1 | 8 | |g volume:86 |g year:2009 |g number:3 |g pages:313-325 |
| 856 | |3 Volltext |u http://www.jstor.org/stable/40294892 |x JSTOR | ||
| 856 | 4 | 0 | |u https://doi.org/10.1007/s10551-008-9849-2 |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 935 | |a mteo | ||
| 936 | u | w | |d 86 |j 2009 |e 3 |h 313-325 |
| 951 | |a AR | ||
| ELC | |a 1 | ||
| ITA | |a 1 |t 1 | ||
| LOK | |0 000 xxxxxcx a22 zn 4500 | ||
| LOK | |0 001 4033693114 | ||
| LOK | |0 003 DE-627 | ||
| LOK | |0 004 1785634232 | ||
| LOK | |0 005 20220112043702 | ||
| LOK | |0 008 220112||||||||||||||||ger||||||| | ||
| LOK | |0 035 |a (DE-Tue135)IxTheo#2021-12-30#22AFADEB65D19580FBBA5CB38D2FCC87BD434583 | ||
| LOK | |0 040 |a DE-Tue135 |c DE-627 |d DE-Tue135 | ||
| LOK | |0 092 |o n | ||
| LOK | |0 852 |a DE-Tue135 | ||
| LOK | |0 852 1 |9 00 | ||
| LOK | |0 866 |x JSTOR#http://www.jstor.org/stable/40294892 | ||
| LOK | |0 935 |a ixzs |a ixrk |a zota | ||
| ORI | |a SA-MARC-ixtheoa001.raw | ||